Toujeo: latest news - GoINPHARMA
Wednesday, 24 April 2019 - 17:06


Sanofi’s Toujeo bests Tresiba in clinical trial with 929 patients

Sanofi has announced today that its insulin Toujeo has met the primary endpoint vs Novo Nordisk’s insulin Tresiba (degludec) in the Bright clinical trial.  Bright has been conducted on 829 patients with type II diabetes and its complete results will…

Jobs at risk in Germany due to Sanofi’s Toujeo performance

Sanofi reported last week its 2016 financial results, together with the performance by Toujeo, the insulin expected to replace the blockbuster Lantus, which has recently lost its patent protection. Toujeo is pivotal for Sanofi’s German branch, which has hired 500…